UKBiobank_logo.svg

UK Biobank

Restricted Access | Catalogue record last updated: 2026/02/20

UK Biobank is a very large and detailed prospective study with over 500,000 participants aged 40 to 69 when recruited in 2006-2010. The study has collected and continues to collect extensive phenotypic and genotypic detail about its participants, including data from questionnaires, physical measures, sample assays, accelerometry, multimodal imaging, genome-wide genotyping and longitudinal follow-up for a wide range of health-related outcomes.


Scientific field(s): Biomedical

Data contained includes the following:
COVID-19 data (testing, vaccines etc)
Demographic and lifestyle (age, sex, education, smoking, diet etc)
Environment (air pollution, socioeconomic index etc)
Genetics and genomics (genotypes, WES, WGS)
Health records (ICD codes, GP data, cancer registry etc)
Imaging (DICOM/NIfTI, derived traits)
Omics (proteomics, metabolomics)
Physical and clinical measures (blood pressure, BMI, spirometry etc)

Data processing level: Processed, Raw
Study design: Longitudinal
Method(s): Whole-genome sequencing, Exome sequencing, Sample collection, Imaging, Interviews, Physical measurements, Questionnaires, Record linkage

Samples are collected from participants (blood, saliva, urine), and physical measurements taken.
Information was collected about participants' health through interviews and online questionnaires.
Genetic data are obtained through WES/WGS sequencing, proteomic, metabolomic and epigenomic assays.
Imaging data are obtained through MRI and OCT imaging.
Data collection also includes linkage to NHS files as well as geospatial linkage and environmental modelling.

Associated ressources:
  • 10.1371/journal.pmed.1001779: Sudlow, C. et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLOS Med. 12, e1001779 (2015).
Catalogue record last updated: Feb. 20, 2026, midnight